<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04572737</url>
  </required_header>
  <id_info>
    <org_study_id>0795</org_study_id>
    <nct_id>NCT04572737</nct_id>
  </id_info>
  <brief_title>Personalised Activity Plan for BREAKing UP Sitting Time in Patients With Peripheral Arterial Disease and Intermittent Claudication (The BREAK UP Study)</brief_title>
  <acronym>BREAK UP</acronym>
  <official_title>Personalised Activity Plan for BREAKing UP Sitting Time in Patients With Peripheral Arterial Disease and Intermittent Claudication (The BREAK UP Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leicester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leicester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intermittent claudication is the most common manifestation of peripheral arterial disease, a&#xD;
      common cardiovascular disease that causes blocked blood vessels (arteries) in the leg.&#xD;
      Symptoms consist of persistent pain in one or both legs during exercise that is relieved with&#xD;
      rest. Evidence suggests that high levels of uninterrupted sitting and sedentary behaviour are&#xD;
      associated with cardiovascular disease risk, mortality and all-cause mortality. One of the&#xD;
      main goals for treating people with intermittent claudication, is increased participation in&#xD;
      physical activity. Supervised Exercise Programmes are recommended however these are not well&#xD;
      tolerated and compliance is low. Alternative exercise, including short bouts of physical&#xD;
      activity to break up sedentary time, has been suggested to help improve physical function.&#xD;
&#xD;
      This study will investigate whether alternative exercise, in the form of breaking up&#xD;
      prolonged sitting time, will improve physical function in patients with intermittent&#xD;
      claudication. A suite of multi-modal activities will be developed offering a variety of&#xD;
      exercise activities which will inform a personalised activity plan for each participant.&#xD;
&#xD;
      Patients will be screened during their routine clinic appointment at Glenfield Hospital. All&#xD;
      other study activity will take place in a laboratory within the Leicester Diabetes Centre at&#xD;
      the Leicester General Hospital (LGH). Patients will be expected to attend LGH for up to a&#xD;
      maximum of 4 visits where study data will be collected from performing physical measurements&#xD;
      and assessments, and the completion of various questionnaires. Additional data will be&#xD;
      collected from activity monitors which will be worn for up to 8 days at baseline and&#xD;
      follow-up, measuring step count and time, inactivity, activity time and intensity, and sleep&#xD;
      duration. Participants will also be expected to wear activity monitors for the duration of&#xD;
      the 8-week intervention to measure steps. Participants will be in the study for approximately&#xD;
      18 weeks in total.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to further COVID-19 restrictions, amendments to the methodology of the study will be&#xD;
      necessary. In this situation the BREAK UP study will be conducted as an 8-week home-based&#xD;
      before and after intervention study with the aim to improve physical function measured via&#xD;
      the WIQ; and to reduce sitting time by up to 60 minutes per day, seven days a week.&#xD;
&#xD;
      Participants will be required to make contact with members of the research team twice to&#xD;
      complete assessments remotely, once to complete a coaching consultation, and once per week&#xD;
      during the 8-week activity plan to discuss their performance. Organisation of these, and any&#xD;
      contact associated with recruitment may require more frequent contact with the research team&#xD;
      via telephone or email.&#xD;
&#xD;
      Contact 1 (Recruitment/ eligibility):&#xD;
&#xD;
      Expression of interest to participate will be sought by the treating clinician at Glenfield&#xD;
      hospital (listed on the delegation log), who will offer the patient a Participant Information&#xD;
      Sheet and consent form. If the participant is happy for a member of the research team to&#xD;
      contact them within two weeks participants will complete a contact details slip during this&#xD;
      visit and a member of the research team will telephone and/or email the participant to&#xD;
      discuss the study in more detail and determine if they wish to participate or not. Should the&#xD;
      patient choose to participate in the study they will be asked to complete the consent form&#xD;
      and post this back to the research team. Once the signed and dated consent form has been&#xD;
      received, the researcher can organise for the baseline data to be collected. In the situation&#xD;
      whereby discrepancies are found with the completion of the informed consent form which has&#xD;
      been returned via post, a member of the research team will contact the participant via&#xD;
      telephone to help the participant complete a new consent form which will be sent and returned&#xD;
      via post.&#xD;
&#xD;
      Contact 2 (Baseline assessments):&#xD;
&#xD;
      Within 2 weeks participants will be required to complete baseline assessments which includes&#xD;
      information on their date of birth/age, sex, ethnicity, smoking status, alcohol consumption,&#xD;
      medical history (co-morbidities) and the questionnaires outlined in 8.3 to assess their&#xD;
      quality of life, breathlessness, anxiety and depression, fatigue and physical function. These&#xD;
      will be completed over the telephone with the researcher or the researcher will post the&#xD;
      questionnaires to the participants which will need to be completed and returned by post.&#xD;
      These assessments will take approximately 1 hour.&#xD;
&#xD;
      Participants will also be posted two activity monitors (monitor 1 and 2) one of which will be&#xD;
      wrist worn and the other thigh worn, as well as information on how to fit these. Participants&#xD;
      will wear these for a period of up to 8 days to collect habitual physical activity data. A&#xD;
      daily sleep-wake log will be used to collect data on participants sleep and wake-time, which&#xD;
      will be posted, along with instructions on how to complete these, and returned via post along&#xD;
      with the activity monitors.&#xD;
&#xD;
      Contact 3 (Coaching consultation):&#xD;
&#xD;
      Within 2 weeks participants will receive a telephone or video call which will be termed a&#xD;
      &quot;coaching consult&quot;, during which sixteen 2-minute activities to break sitting time will be&#xD;
      discussed with a member of the research team. These two-minute activities are outlined in&#xD;
      Figure 1. Video tutorials and/or instruction cards of these activities will be sent via post&#xD;
      prior to the coaching consult. These activities and data from the habitual physical activity&#xD;
      measure will be used to inform personalised activity plans whereby participants will be&#xD;
      encouraged, using Bandura's social cognitive theory, to use these activities to reduce&#xD;
      sitting time by up to 60 minutes per day for 8-weeks. This contact will take approximately&#xD;
      1-hour. The 8-week activity plan will be prescribed, to complete at home and will begin&#xD;
      within 2 weeks of this contact.&#xD;
&#xD;
      Participants will wear a wrist-worn activity monitor for the duration of the home-based&#xD;
      8-week intervention (monitor 3). They will be instructed on how to use these during the&#xD;
      coaching consultation and how to complete daily diaries for monitor wear and activity&#xD;
      completion for the 8-week period.&#xD;
&#xD;
      During the 8-week intervention participants will be contacted once a week via telephone or&#xD;
      video to discuss their performance on the activity plan and completion of the daily diary.&#xD;
      This will take approximately one hour a week. A member of the research team will organise&#xD;
      this over email or telephone.&#xD;
&#xD;
      A second 8-day habitual physical activity measurement period will take place during week 8 of&#xD;
      the intervention. Activity monitors 1 and 2 will be posted to participants in good time along&#xD;
      with instructions on how to fit these. During this second habitual physical activity&#xD;
      measurement period participants will continue to wear wrist-worn activity monitor 3 as well.&#xD;
&#xD;
      Contact 4 (Follow-up):&#xD;
&#xD;
      Participants will then be contacted for their final assessments within one week of the end of&#xD;
      the 8-week intervention. The follow-up assessments will include the same assessments as at&#xD;
      baseline, except for the Sarc-F questionnaire, and will be completed via telephone with a&#xD;
      member of the research team, or a researcher will be post these out to the participant for&#xD;
      completion. The assessments will take approximately 1 hour.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>before and after intervention study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate overall changes in sitting time</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The walking impairment questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>Total score for 16 questions measuring walking distance, speed and stair climbing from 0 (worst/inability) to 4 (best/without limitations)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent performing physical activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent performing physical activity at baseline vs. follow up assessed via mean acceleration mg/day )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent in light physical activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent in light physical activity at baseline vs. follow up assessed via acceleration mins/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent in moderate physical activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent in moderate physical activity at baseline vs. follow up assessed via acceleration mins/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent in vigorous physical activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent in vigorous physical activity at baseline vs. follow up assessed via acceleration mins/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent in prolonged sitting</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate overall changes in time spent in sleep</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using accelerometers (comparison of time spent sleeping at baseline vs. follow-up assessed via acceleration)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate whether personalised activity breaks in sitting time improve quality of life</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the Vascular Quality of Life (VascuQoL) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate whether personalised activity breaks in sitting time improve quality of life</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the Euro Quality of Life (EQ-5D-5L) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate whether personalised activity breaks in sitting time improve breathlessness</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the modified medical research council (mMRC) dyspnoea scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate whether personalised activity breaks in sitting time improve fatigue</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using Chalder's Fatigue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate whether personalised activity breaks in sitting time improve anxiety and depression</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the hospital anxiety and depression scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will take part in an 8-week home-based activity plan to break up sitting time by 60 minutes per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Activity plan to break up sitting time</intervention_name>
    <description>This research study aims to prove efficacy of a home-based physical activity intervention targeted at reducing periods of prolonged sitting and improving physical function in patients with intermittent claudication.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women&#xD;
&#xD;
          -  Age 40 to 80 years, inclusive&#xD;
&#xD;
          -  ABPI &lt;0.9 or &gt;1.3 at rest OR &lt;0.9 during treadmill exercise testing&#xD;
&#xD;
          -  History of intermittent claudication (exercise induced, aching/cramping, pain&#xD;
             affecting the lower limbs or buttocks, which subsides with rest)&#xD;
&#xD;
          -  Able and willing to give informed consent&#xD;
&#xD;
          -  Able to speak, read, and write English&#xD;
&#xD;
          -  Able to undertake light physical activity&#xD;
&#xD;
          -  Weight stable; â‰¤ 3kg weight change in preceding 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals with type 1, gestational, or monogenic diabetes mellitus&#xD;
&#xD;
          -  On insulin therapy&#xD;
&#xD;
          -  Hospital admission in preceding 3 months&#xD;
&#xD;
          -  Current or planned pregnancy, or breast feeding&#xD;
&#xD;
          -  Contra-indications to exercise&#xD;
&#xD;
          -  Participation in CTIMP currently and/or in preceding 3 months&#xD;
&#xD;
          -  Already participating in a structured SEP&#xD;
&#xD;
          -  Serious illness with life-expectancy &lt; 1 year&#xD;
&#xD;
          -  Previous major amputation&#xD;
&#xD;
          -  Recent cardiovascular event (within the last 12 months)&#xD;
&#xD;
          -  Comorbidity that the research team considered to be a contraindication to involvement&#xD;
             in the study&#xD;
&#xD;
          -  Unable to communicate in English&#xD;
&#xD;
          -  Recent diagnosis or treatment for cancer (within 12 months)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>J Perks</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>J Perks</last_name>
      <phone>01162583669</phone>
      <email>jp549@le.ac.uk</email>
    </contact>
    <contact_backup>
      <phone_ext>Perks</phone_ext>
      <email>jp549@le.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Rob Sayers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2020</study_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intermittent claudication</keyword>
  <keyword>exercise</keyword>
  <keyword>physical activity</keyword>
  <keyword>prolonged sitting</keyword>
  <keyword>sedentary time</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Once we have analysed the results, we will present our findings at scientific meetings and publish in medical research journals. All these results will be anonymous, and it would not be possible to identify participants.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

